Ultrahuman is a technology company.
Ultrahuman has raised $51.0M across 3 funding rounds.
Ultrahuman has raised $51.0M in total across 3 funding rounds.
Ultrahuman has raised $51.0M in total across 3 funding rounds.
Ultrahuman's investors include Blume Ventures, Global Founders Capital, Kunal Shah, AngelList, Battery Ventures, Bessemer Venture Partners, Bling Capital, Flourish Ventures, General Catalyst, GSV Acceleration, Helion Venture Partners, KHOCEL INVEST.
Ultrahuman is a Bangalore-based health technology company founded in 2019-2020, specializing in wearables and software for self-quantification and personalized health insights.[3][5] It builds products like the Ultrahuman Ring AIR (world's lightest sleep-tracking smart ring at 2.4 grams), Ultrahuman M1 (continuous glucose monitor), Blood Vision (preventive blood testing with UltraTrace™ tech), Ultrahuman Home (environmental health tracker), and modular PowerPlugs such as Cycle & Ovulation Pro for reproductive tracking.[1][2][4][5] These serve athletes, wellness enthusiasts, and everyday users seeking data-driven optimization of sleep, recovery, movement, metabolism, glucose, cycles, and blood markers, solving fragmented health tracking by unifying biomarkers into a comprehensive ecosystem.[1][2][5][6]
The company targets performance-driven individuals, including pro cycling teams like Team UAE Emirates and Roojai Insurance, powering champions with insights on HRV, fueling, and recovery.[2][6] Ultrahuman demonstrates strong growth momentum, achieving 5.4× YoY revenue growth and record FY25 profits through its high-margin subscription engine, positioning it as a profitability leader in wearables.[4]
Ultrahuman was co-founded in 2019 by Mohit Kumar (CEO) and Vatsal Singhal, both with prior experience building Runnr, a hyperlocal delivery startup that merged with Zomato in 2017.[3][5] Mohit, a serial entrepreneur, cyclist, and Brazilian Jiu-Jitsu practitioner, drew inspiration during martial arts training at Tiger Muay Thai in Thailand, where he saw athletes leveraging biomarkers like glucose, HRV, and blood work for performance optimization.[5] Vatsal, a CrossFit athlete, complemented this vision for data-backed health tools.[5]
The idea emerged from this hands-on observation of elite recovery practices, leading to Ultrahuman's app launch in January 2021 at CES Los Angeles, where it won the Best of CES Award—marking early traction in the health-tech space.[5] Pivotal moments include expanding from wearables to a full ecosystem and recent acquisitions like viO HealthTech in 2025, integrating 15-year-old OvuSense™ tech for 90%+ accurate ovulation tracking.[1]
Ultrahuman rides the longevity and preventive health trend, capitalizing on rising demand for continuous, non-invasive monitoring amid aging populations and athlete optimization.[2][4] Timing aligns with post-pandemic wellness focus and AI-driven personalization, where wearables evolve from fitness trackers to medical-grade ecosystems—evidenced by TIME's 2025 Top 100 Healthtech nod.[4] Market forces like subscription models (high margins) and acquisitions (viO for women's health) favor its scalability, challenging giants like Oura or Whoop by emphasizing affordability, comfort, and unified data.[1][4]
It influences the ecosystem by partnering with sports bodies (e.g., USA Bobsled) and teams, democratizing pro-level insights and pushing boundaries in reproductive/metabolic tracking.[2][6]
Ultrahuman's profitability and ecosystem expansion signal a shift from hardware to software dominance, with PowerPlugs unlocking medical value like ovulation and glucose nudges.[1][4] Next steps likely include global rollouts (USA/UK/EU/Aus/Canada), more acquisitions, and AI enhancements for predictive health—shaped by longevity trends, women's health data gaps, and athlete endorsements.[1][6] Its influence may grow as the lightest, most comprehensive platform, potentially redefining accessible self-quantification and tying back to its origins in elite biomarker use for everyday peak performance.[5]
Ultrahuman has raised $51.0M across 3 funding rounds. Most recently, it raised $25.0M Series B in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $25.0M Series B | Blume Ventures, Global Founders Capital, Kunal Shah | |
| Aug 1, 2021 | $18.0M Series B | AngelList, Battery Ventures, Bessemer Venture Partners, Bling Capital, Blume Ventures, Flourish Ventures, General Catalyst, Global Founders Capital, GSV Acceleration, Helion Venture Partners, KHOCEL INVEST, Lightspeed India Partners, NewFund, Qiming Venture Partners, Tiger Global Management, Vibe Capital, Akhil Paul, Alvin Tse, Anthony Citrano, Balaji Srinivasan, Christopher Zemina, Chuhan Wang, Dheeraj Pandey, Gaurav Munjal, Gokul Rajaram, Kunal Shah, Roman Saini | |
| Nov 1, 2020 | $8.0M Series A | Blume Ventures, Global Founders Capital, Kunal Shah |